Stockreport

Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF Net Cash Used in Operating Activities: $8.6 million for Q3 2024, significantly lower than $46.1 million in Q3 2023. Collaboration Revenue: $12.6 million for Q3 2024, [Read more]